我國惡性腫瘤發(fā)病人數(shù)居全球第一，而感染是惡性腫瘤常見的并發(fā)癥，嚴(yán)重影響惡性腫瘤患者的療效，延長住院時間，增加治療費(fèi)用，成為惡性腫瘤患者死亡的重要原因。近年來，隨著抗菌藥物的廣泛應(yīng)用，惡性腫瘤患者發(fā)生多重耐藥菌感染比率逐年升高，對患者造成極大危害。因此提升對惡性腫瘤患者發(fā)生多重耐藥菌感染的危險(xiǎn)因素的認(rèn)識至關(guān)重要，故對惡性腫瘤患者發(fā)生多重耐藥菌感染的危險(xiǎn)因素進(jìn)行綜述，以期為臨床提供預(yù)防多重耐藥菌感染的參考。

The number of cancer patients in China ranks first in the world, and infection is a common complication of cancer, which seriously affects the treatment effect of cancer patients. Prolonging hospital stay and increasing treatment costs have become an important cause of death of cancer patients. In recent years, with the wide application of antibiotics, the infection rate of multidrug resistant organisms (MDRO) in patients with malignant tumor is increasing year by year, which causes great harm to patients. Therefore, it is very important to improve the understanding of the risk factors of MDRO infection in patients with malignant tumor, so this paper reviews the risk factors of MDRO infection in patients with malignant tumor, in order to provide reference for clinical prevention of MDRO infection.

R979.1

國家自然科學(xué)基金資助項(xiàng)目（81703454）